Target intelligence / Profile preview

Tumor cell membrane and vasculature disruption via photodynamic effect

Molecular classification
Other (therapeutic process/mechanistic outcome), If mapping required: related to "Membrane protein", Vascular endothelial cells, Blood vessel components
01

Overview

The phrase describes the therapeutic effect of Photodynamic Therapy (PDT), a procedure where a photosensitizing drug is administered and preferentially accumulates in cancer cells and associated vasculature. Upon irradiation with light of a specific wavelength, the drug becomes activated, generating reactive oxygen species (mostly singlet oxygen). These ROS rapidly damage cellular membranes and the structural components of blood vessels within the tumor, leading to cell death, blockage of tumor blood supply, tumor hypoxia, and immune activation. This mechanism is utilized for localized cancer treatment, targeting both the tumor parenchyma and its supporting microvasculature, and is not a single molecular target but a multi-faceted biological response.

Other names
Photodynamic-induced tumor membrane disruptionPhotodynamic-induced tumor vasculature ablation
02

Mechanism of action

Generation of reactive oxygen species (ROS) upon photosensitizer activation by light Selective destruction of tumor cell membranes and tumor vasculature through oxidative damage

03

Biological functions

Cell death (apoptosis, necrosis)Disruption of tumor cell membranesVascular damage (tumor blood vessel injury)Induction of hypoxiaImmune response activation (secondary effect)
04

Disease associations

Cancer
05

Safety considerations

Off-tumor toxicity (damage to nearby normal tissue or vasculature)Photosensitivity reactionsIncomplete tumor ablation due to light penetration limitsHypoxia-induced resistance/recurrence
06

Interacting drugs

Photodynamic therapy photosensitizers (e.g., porphyrins, aminolevulinic acid, temoporfin)
07

Biomarkers

Uptake of photosensitizer by tumor cellsFluorescence imaging for photosensitizer localizationExpression of vessel-specific markers (e.g., VEGF, CD31; indirect relevance)

Beyond the preview

Go deeper on Tumor cell membrane and vasculature disruption via photodynamic effect.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor cell membrane and vasculature disruption via photodynamic effect.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call